Skip to content

Medical emergency? What to do

Australia scientists work on anti-Alzheimer's pill

3-RXPublished July 25, 20062 min read

Key points

  • Australian mental health researchers have developed a once-a-day pill they believe might stop or slow the onset of Alzheimer's disease, with human trials expected within two months.
  • Institute director George Fink said on Monday the drug attacked one of the root causes of Alzheimer's, a degenerative brain disease and the most common form of dementia, particularly in people over the age of 65.
  • The institute, which is working in collaboration with Prana Biotechnology Limited, made public its PBT2 trial results at the 10th International Conference on Alzheimer's Disease held in Madrid last week.
  • The tests required mice to remember the location of submerged platforms, requiring the mice to employ higher-level learning and spatial memory skills to successfully navigate a maze.

Australian mental health researchers have developed a once-a-day pill they believe might stop or slow the onset of Alzheimer's disease, with human trials expected within two months.

A 15-month trial on mice showed the drug called PBT2 reduced the amyloid protein, which many scientists believe causes Alzheimer's, by 60 percent within 24 hours, said researchers at The Mental Health Research Institute of Victoria.

Institute director George Fink said on Monday the drug attacked one of the root causes of Alzheimer's, a degenerative brain disease and the most common form of dementia, particularly in people over the age of 65.

"We think the drug can help best at an early phase of the disease to intervene and prevent further development of the disease -- nipping it in the bud," Fink told local radio.

The institute, which is working in collaboration with Prana Biotechnology Limited, made public its PBT2 trial results at the 10th International Conference on Alzheimer's Disease held in Madrid last week.

The institute and Prana said mice that took the drug orally showed improved memory performance after four days.

The tests required mice to remember the location of submerged platforms, requiring the mice to employ higher-level learning and spatial memory skills to successfully navigate a maze.

"It was demonstrated that PBT2 could quickly and significantly improve spatial memory -- an important barometer of cognitive function," said Prana in a statement.

The institute's tests also showed that PBT2 blocked the interaction between the amyloid protein and metals such as copper and zinc in the brain, stopping the development of Alzheimer's. Amyloid accumulates more rapidly in the presence of metals.

Human trials of PBT2 in patients with early Alzheimer's are expected to begin in Sweden within two months, said the institute.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.